Xuezhen Ma

434 total citations
24 papers, 274 citations indexed

About

Xuezhen Ma is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xuezhen Ma has authored 24 papers receiving a total of 274 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Xuezhen Ma's work include RNA modifications and cancer (7 papers), Cancer-related molecular mechanisms research (3 papers) and Cancer-related gene regulation (3 papers). Xuezhen Ma is often cited by papers focused on RNA modifications and cancer (7 papers), Cancer-related molecular mechanisms research (3 papers) and Cancer-related gene regulation (3 papers). Xuezhen Ma collaborates with scholars based in China, United States and Hong Kong. Xuezhen Ma's co-authors include Ju Fang, Lin Lü, Hui Zhao, Yuan Yao, Zhihai Wang, Hui Zhao, Bin Wu, Ke Zhang, Shicui Zhang and Weiyu Chen and has published in prestigious journals such as Angewandte Chemie International Edition, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Xuezhen Ma

18 papers receiving 270 citations

Peers

Xuezhen Ma
Xuezhen Ma
Citations per year, relative to Xuezhen Ma Xuezhen Ma (= 1×) peers Catherine Fan

Countries citing papers authored by Xuezhen Ma

Since Specialization
Citations

This map shows the geographic impact of Xuezhen Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuezhen Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuezhen Ma more than expected).

Fields of papers citing papers by Xuezhen Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuezhen Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuezhen Ma. The network helps show where Xuezhen Ma may publish in the future.

Co-authorship network of co-authors of Xuezhen Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Xuezhen Ma. A scholar is included among the top collaborators of Xuezhen Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuezhen Ma. Xuezhen Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zhang, Shengjie, Min Zhang, Xiaohua Li, et al.. (2025). Screening of an antibacterial peptide with high antibacterial activity against superbugs and its application in the treatment of skin wound infections. Chemical Engineering Journal. 522. 167748–167748.
3.
Zhang, Lei, Xuezhen Ma, Yaohui He, et al.. (2025). Rbm38 deficiency impairs erythroid heme biosynthesis and induces porphyria via reduced ferrochelatase expression. Blood. 146(25). 3106–3123.
4.
Zhang, Shicui, et al.. (2024). Anticancer activities of natural antimicrobial peptides from animals. Frontiers in Microbiology. 14. 1321386–1321386. 27 indexed citations
5.
Yu, Chao, et al.. (2024). Prognostic value of immunotherapy in advanced NSCLC based on baseline and dynamic changes in HALP. SHILAP Revista de lepidopterología. 25(1). 29–41. 2 indexed citations
6.
Li, Zenghui, Yuqing Feng, Weiyu Chen, et al.. (2024). A Stapled Peptide Inhibitor Targeting the Binding Interface of N6‐Adenosine‐Methyltransferase Subunits METTL3 and METTL14 for Cancer Therapy. Angewandte Chemie International Edition. 63(24). 30 indexed citations
7.
Li, Jie, Hao Dong, Zhiqian Wang, et al.. (2024). Integrative analysis of LAG3 immune signature and identification of a LAG3-related genes prognostic signature in kidney renal clear cell carcinoma. Aging. 16(3). 2161–2180. 2 indexed citations
10.
Ma, Xuezhen, Ning Yang, Zhen Xu, et al.. (2023). The Combination of Inositol Hexaphosphate and Inositol Inhibits Metastasis of Colorectal Cancer Cells by Upregulating Claudin 7. Biological and Pharmaceutical Bulletin. 46(8). 1145–1151.
11.
Li, Z, Meng Su, Pan Wang, et al.. (2023). mDia formins form hetero-oligomers and cooperatively maintain murine hematopoiesis. PLoS Genetics. 19(12). e1011084–e1011084. 1 indexed citations
12.
Ma, Xuezhen, et al.. (2022). An update on the roles of circular RNAs in spinal cord injury. Molecular Neurobiology. 59(4). 2620–2628. 8 indexed citations
13.
Su, Meng, Kehan Ren, Xuezhen Ma, et al.. (2022). Clonal hematopoiesis and bone marrow inflammation. Translational research. 255. 159–170. 5 indexed citations
14.
Wang, Zhiqian, et al.. (2022). Epiplakin1 promotes the progression of esophageal squamous cell carcinoma by activating the PI3K‐AKT signaling pathway. Thoracic Cancer. 13(8). 1117–1125. 6 indexed citations
15.
Liu, Shujuan, et al.. (2017). Increased cycles of DC/CIK immunotherapy decreases frequency of Tregs in patients with resected NSCLC. International Immunopharmacology. 52. 197–202. 19 indexed citations
16.
Wang, Li‐Fang, et al.. (2017). HuR stabilizes lnc-Sox5 mRNA to promote tongue carcinogenesis. Biochemistry (Moscow). 82(4). 438–445. 16 indexed citations
17.
Lü, Lin, Ju Fang, Hui Zhao, & Xuezhen Ma. (2015). MicroRNA-134 modulates resistance to doxorubicin in human breast cancer cells by downregulating ABCC1. Biotechnology Letters. 37(12). 2387–2394. 47 indexed citations
18.
19.
Fang, Ju, et al.. (2015). ING5 inhibits epithelial-mesenchymal transition in breast cancer by suppressing PI3K/Akt pathway.. PubMed. 8(9). 15498–505. 29 indexed citations
20.
Song, Guohong, Xi Zhang, Ying Cheng, et al.. (2011). Multicenter clinical study for evaluation of efficacy and safety of transdermal fentanyl matrix patch in treatment of moderate to severe cancer pain in 474 Chinese cancer patients. Chinese Journal of Cancer Research. 23(4). 317–322. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026